black
diamond
therapeutics
present
morgan
stanley
annual
global
healthcare
conference
cambridge
mass
new
york
globe
newswire
black
diamond
therapeutics
nasdaq
bdtx
precision
oncology
medicine
company
pioneering
discovery
development
small
molecule
therapies
today
announced
president
chief
executive
officer
david
epstein
present
update
company
progress
morgan
stanley
annual
global
healthcare
conference
presentation
take
place
tuesday
september
pm
et
live
webcast
presentation
accessed
visiting
investor
relations
section
company
website
replay
presentation
also
available
archived
site
three
weeks
black
diamond
black
diamond
therapeutics
precision
oncology
medicine
company
pioneering
discovery
small
molecule
therapies
black
diamond
targets
undrugged
mutations
patients
genetically
defined
cancers
black
diamond
built
upon
deep
understanding
cancer
genetics
protein
structure
function
medicinal
chemistry
company
proprietary
technology
platform
map
platform
designed
allow
black
diamond
analyze
genetic
sequencing
data
identify
oncogenic
mutations
promote
cancer
across
tumor
types
group
mutations
families
develop
single
small
molecule
therapy
manner
targets
specific
family
mutations
black
diamond
founded
david
epstein
elizabeth
buck
beginning
together
versant
ventures
began
building
map
platform
chemistry
discovery
engine
information
please
visit
contacts
investors
natalie
wildenradt
investors
